Clinical Trials Logo

Clinical Trial Summary

Approximately 340 participants (680 eyes) will be enrolled in this three-month, two-arm, 1:1 randomized, parallel-group, bilateral, double-masked study at approximately 22 investigative sites in the United States. Participants will be required to wear dispensed study lenses on a daily wear basis for three months with scheduled in-office replacement of study lenses at the 1-Month and 2-Month Follow-Up Visits.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05565937
Study type Interventional
Source Bausch & Lomb Incorporated
Contact
Status Completed
Phase N/A
Start date April 12, 2023
Completion date February 28, 2024

See also
  Status Clinical Trial Phase
Completed NCT06098937 - Kalifilcon A Toric Compared to Commercially Available Lenses N/A
Completed NCT06053736 - 1-Week Dispensing Evaluation of REVIVEā„¢ Toric Soft Contact Lenses N/A
Completed NCT04085328 - Assessment of an Investigational Frequent Replacement Silicone Hydrogel Lens N/A
Completed NCT01484028 - Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens N/A
Completed NCT01484054 - Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens N/A
Completed NCT05765227 - Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens N/A
Completed NCT05790928 - Air Optix Night and Day Aqua (AONDA) Retrospective Study 1
Completed NCT04013789 - Comparison of Two Daily Disposable Lenses N/A